Fifty-five patients with osteoarthritis, rheumatoid arthritis or spondyloarthritis, joint pain and other rheumatic-inflammatory disorders were treated with proglumetacin, at different doses, during 3-60 days. Assessment of therapeutic efficacy indicated 88.9% of good results. Joint pain progressively decreased during the whole period of observation. Tolerance was considered good or very good in 78% of patients.
|Translated title of the contribution||Proglumetacin: A flexible and wide-spectrum anti-rheumatic drug in clinical practice|
|Number of pages||5|
|Publication status||Published - 1983|
ASJC Scopus subject areas